This round has now closed, for round 2 on Advanced Therapies please click here

Collaborate to Innovate round 1 is an exciting programme in the broad life sciences domain which launched in early 2016, funded by the Higher Education Funding Council for England (HEFCE) and match funded by the European Regional Development Fund (ERDF), with the aim to promote knowledge transfer and commercialisation of innovations.

Collaborate to Innovate round 1 is managed centrally by MedCity and delivered through the following academic delivery partners:

  • King’s College London
  • Imperial College London
  • University College London
  • Queen Mary University of London

Collaborate to Innovate round 1 targeted SMEs with ambitions to embark on innovative projects in the applied research/clinical domain, or who wished to bring new products and services to market. It matched the SMEs to academic research groups with complementary expertise.

The selected companies and academics are working on collaborative research projects (CRPs), in domains such as drug discovery, devices, diagnostics and digital health. There are fifteen projects supported by Collaborate to Innovate round 1.

CRPs:
• Have up to £100,000 support available in eligible costs
• Are typically 6-12 months in duration
• All costs are borne by the academic partner, conforming to ERDF regulations

MedCity announced the chosen collaborations at a launch event on 16 March 2017.